Your browser doesn't support javascript.
loading
The RTS,S vaccine-a chance to regain the upper hand against malaria?
Sinnis, Photini; Fidock, David A.
Afiliação
  • Sinnis P; Johns Hopkins Malaria Research Institute and Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: psinnis1@jhu.edu.
  • Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: df2260@cumc.columbia.edu.
Cell ; 185(5): 750-754, 2022 03 03.
Article em En | MEDLINE | ID: mdl-35245476
ABSTRACT
Malaria is estimated by the World Health Organization (WHO) to have killed 627,000 individuals worldwide in 2020, with nearly 80% of deaths in African children younger than five. The recent WHO approval of the RTS,S/AS01 vaccine, which targets Plasmodium falciparum pre-erythrocytic stages, provides hope that its use combined with other interventions can help reverse the current malaria resurgence.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Limite: Child / Humans / Infant Idioma: En Revista: Cell Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas / Malária Limite: Child / Humans / Infant Idioma: En Revista: Cell Ano de publicação: 2022 Tipo de documento: Article